The following article is adapted and reprinted from the M&A Tax Report, Vol. 9, No. 10, May 2001, Panel Publishers, New York, NY.
TREATMENT OF OPTIONS IN M&A DEALS
By Robert W. Wood, San Francisco The real interesting question to M&A Tax Report subscribers ought
to be how NSOs and ISOs are treated in transactions. If one sets aside
as a subset the golden parachute rules (which, because of space limitations,
we won't consider here), there is still plenty to know and do when dealing
with outstanding ISOs and/or NSOs held either by the acquiring or the Target
company.
In many transactions, the buyer and Target will agree that the Target's
obligations under its options plans will be assumed by the buyer. Often,
substitute options to purchase buyer's stock will be swapped for the outstanding
options to purchase the Target stock. Generally, the buyer will be able
to make this substitution so that the employee/optionholders are not taxable
on this substitution itself. In such a substitution, the Target's optionholders
will generally be able to preserve the gain inherent in their old Target
options, while maintaining a continuing stake in the appreciation of the
ongoing (post-acquisition) enterprise.
Given the elaborate regime for ISOs — and (by comparison) the loosey-goosey
rules for NSOs — ISOs and NSOs need to be separately considered in an analysis
of assumptions and substitutions of options.
Assuming/Substituting ISOs
Where the Target has outstanding ISOs, one huge concern will be preserving
the qualified ISO status of those options. Some option plans contain hidden
traps that would disqualify the ISO treatment. For example, the Target's
plan may provide that ISOs vest automatically on a change in control. This
could cause a large number of options to lose ISO status because of the
annual dollar cap ($100,000) mentioned earlier.
It is also important to insure that the assumption does not result
in a "modification" of the ISOs. Modification here is a technical term
with (perhaps not surprisingly) negative consequences. A modification may
occur if the option terms change, giving the employee additional benefits.
The reason the determination whether an ISO is modified is so important
is what happens if it is treated as modified: the option is treated as
reissued as of the date of the modification. On this point, see I.R.C.
§424(h)(1); Reg. §1.425-1(e)(2).
This reissuance treatment means the option will be retested as of
that moment to see if it satisfies all of the ISO requirements. Recall
the long list of requirements that must be satisfied for an option to qualify
as an ISO (see "Tax and Accounting Treatment of ISOs" above). It is a fairly
odious list. For a variety of reasons, especially the fair market value
of the underlying shares in the context of a merger or acquisition, it
may well exceed the option exercise price and thus preclude ISO treatment
if this retesting must occur.
Specialized Meaning of "Corporate Transaction"
Still, there may be a silver lining here. If an ISO is substituted
or assumed in a "corporate transaction," that substitution or assumption
is not treated as a modification (1) as long as the new option satisfies
a "spread test," and a "ratio test," and (2) as long as it does not provide
additional benefits that were not provided under the old option. Before
defining the spread and ratio tests, let's look at what constitutes a "corporate
transaction."
Two conditions must be met before a transaction will be considered
a corporate transaction. First, the transaction must involve one of the
following: a merger or consolidation, an acquisition of property or stock
by any corporation, a spinoff, split-up or split-off, a reorganization
or any partial or complete liquidation (see I.R.C. §424(a); Reg. §1.425-1(a)(1)(ii)).
Note that it is irrelevant whether the transaction qualifies as a tax-qualified
reorganization under Section 368 of the Code. The second requirement is
that the transaction must result in a significant number of employees being
transferred to a new employer, or discharged. (And, yes, there can be debates
about the relative meaning of the term "significant number of employees"
here!)
Spread and Ratio Tests
Assuming a corporation transaction (as defined) has occurred, the
assumption or substitution of the ISO will be fine, as long as both the
"spread" and "ratio" tests are met. The spread test is met if the aggregate
spread of the new option (immediately after the substitution or assumption)
is not more than the aggregate spread of the old option immediately before
the substitution or assumption. This "spread" is the excess of the aggregate
fair market value of the shares subject to the option over the aggregate
option price for those shares. (See I.R.C. §424(a)(1); Reg. §1.425-1(a)(1)(i).)
The "ratio" test is met by doing a share-by-share comparison. The
ratio of the option price to the fair market value of the shares subject
to the new option immediately after the substitution or assumption must
be no more favorable to the optionee than the ratio of the option price
to the fair market value of the shares subject to the old option (immediately
before the substitution or assumption). This spread test is only regulatory
(it does not appear in the Code itself). Examples in the Regulations help
explain and illustrate both the spread and the ratio tests. See Reg. §1.425-1(a)(4).
Predictably, there are some determinations to be made in assessing
whether these tests are met. For both tests, the parties may adopt "any
reasonable method" to determine the fair market value of the stock subject
to the option. Stock listed on an exchange can be based on the last sale
before the transaction or the first sale after the transaction, as long
as the sale clearly reflects the fair market value. Or, an average selling
price may be used during a longer period. The fair market value can also
be based on the stock value assigned for purposes of the deal (as long
as it is an arms'-length deal).
Watch Out
Even if one gets over the "corporate transaction" hurdle, the "spread"
hurdle and the "ratio" hurdle, someone must also analyze the transaction
to determine whether the new option provides any "additional benefits"
to the optionholders. If it does, the ISOs assumed or substituted will
be a problem. The new option must not provide the optionholder with additional
time to exercise or more favorable terms for paying the exercise price.
Significantly, though, shortening the period during which the option may
be exercised (or accelerating vesting) are not treated as additional benefits.
The acceleration of vesting exception is an important one and is widely
used.
Cancelling ISOs
Although the rules regarding assumption of ISOs are complex (actually,
more complex than the above brief summary indicates) and a variety of issues
can come up in that context, cancelling ISOs turns out to be remarkably
simple. The tax consequences on a cancellation of ISOs are governed by
Section 83 of the Code. If the ISO does not have a readily ascertainable
fair market value at the time it was granted, then Section 83 requires
that the cash or property received in cancellation of the option be treated
the same as if the cash or property were transferred pursuant to the exercise
of the option. (See Reg. §1.83-7(a).)
Thus, if the cash or property received on cancellation is fully vested,
then the optionholder would recognize income on the cancellation of the
option equal to this amount (less any amount paid by the optionholder to
acquire the option, typically nothing). This income constitutes wages subject
to withholding for income and employment taxes, and will generate a corresponding
deduction to the company.
Where the property received in exchange for the option (on its cancellation)
is not substantially vested (let's say restricted stock is used, for example),
then the cancellation transaction will not be taxable until the property
becomes substantially vested. Again, these are the rules set out in (and
in the regulations underlying) Section 83. Consequently, it should be possible
for the employee to elect to take the property even before substantial
vesting into income by making a Section 83(b) election.
Treatment of NSOs in Deal
The treatment of NSOs in a transaction, as with the initial issuance
of NSOs, is a good deal simpler than the rules for ISOs. If a buyer wishes
to assume the Target's NSOs, one looks to Section 83 to determine the tax
consequences to both the optionholders and the company. Recall that Section
83 does not generally apply to the grant of an option without an ascertainable
fair market value. If an employee exchanges an NSO that does not have a
fair market value in an arms'-length transaction, the question is what
he or she gets. Section 83 will apply to the transfer of the money (or
other property) received in exchange.
Thus, if the new NSO received in exchange for the old NSO does not
have a readily ascertainable fair market value, the employee will not recognize
income in the exchange, nor will the company get a deduction. Of course,
NSOs may have some value when they are issued. Yet, this value generally
is not readily ascertainable unless the option is actively traded on an
established market. Assuming it is not actively traded on an established
market, it will not have a readily ascertainable value unless all of the
following exist for the option:
it is transferable; it is immediately exercisable in full; it (or the property subject to the option) is not subject to any restriction
or condition, other than a lien or other condition to secure payment, that
has a significant effect on the fair market value of the option; and its fair market value is readily ascertainable in accordance with the
Regulations. See Reg. §1.83-7(b). Most NSOs do not satisfy all four
of these conditions, so don't have a readily ascertainable fair market
value. Unlike ISOs, with an NSO there is no need to focus on whether the assumption
or substitution of the NSO results in a "modification." There is simply
no qualified status to interrupt. Thus, the holder of an NSO should not
recognize income where the terms of the new option are different than the
terms of the old. This is somewhat of a murky area, though.
For example, suppose the new option has an exercise price that is
nominal in relation to the fair market value of the underlying shares.
Here, the optionholder may have to recognize the income on the transaction.
If the buyer chooses to give the optionholder an alternative, to convert
the option into an option in the buyer, or to take cash (or other property)
for the option now, the situation is also easier with NSOs than with ISOs.
Someone choosing cash will recognize income in an amount equal to the amount
of cash received, less any amount paid for the option (but the amount paid
is most typically zero). An optionholder who elects not to take cash should
not be taxed.
Cancellation of NSOs
One place where the rules for ISOs and NSOs are remarkably parallel
concerns cancellation. Although most of the complexity associated with
the treatment of options (either ISOs or NSOs) in merger and acquisition
transactions involves assumptions and substitutions, not too much can go
wrong when it comes to a cancellation. If the NSOs are simply canceled
in the deal, then the employee looks to Section 83 to determine how he
or she is taxed. Remarkably, this is the same set of rules that will apply
when an ISO is cancelled. Thus, the above discussion concerning cancellation
of ISOs applies to cancellation of NSOs as well.
Accounting Treatment Change
Finally, there can be accounting issues on a modification. Under
Financial Accounting Standards Board Interpretation No. 44 (FIN 44), Accounting
for Certain Transactions Involving Stock Compensation, an assessment as
to whether the proposed modification provides for a change to the life
of the employee stock options through an extension of the exercise period
or a renewal of the exercise period would need to be made. The assessment
should also determine whether the modification changes the exercise price
of the employee stock options or the number of shares the employee is entitled
to receive.
A modification that does not affect the life of the stock option,
the exercise price, or the number of shares to be issued has no accounting
consequence. In most cases, a modification of this type would not affect
the life of the stock option, the exercise price, or the number of shares
to be issued. Accordingly, a new measurement date would not be deemed to
have occurred.
Treatment of Options in M&A Deals, Vol. 9, No. 10, M&A
Tax Report (May 2001), p. 5.